The aims of the ReFLeCT study were to evaluate the clinical safety and effectiveness of switching to degludec from other basal insulins in routine clinical care of insulin-treated adults with T1D or T2D attending multiple diabetes centers across Europe. Here, INS is linked to type 1 diabetes mellitus.